VITL Vital Farms Inc

Previous close
$11.02
Est. 12 months change
+19.51%
Projected Price
$13.19

Profitability Metrics

Return on Equity (ROE)
0.05%
Return on Assets (ROA)
0.04%
Return on Invested Capital (ROIC)
0.01%
Weighted Average Cost of Capital (WACC)
8.33%
ROIC - WACC
-8.32%
Updated : 2026-08-18 20:11 ET

Valuation Metrics

P/E Ratio
1798.15
Forward P/E
18.13
PEG Ratio
141.65
Debt Current Ratio
1.10

Growth & Cash Flow

Gross Margin
28.12%
Operating Margin
0.04%
FCF Margin
16.47%
TTM Revenue Growth
25.26%
Projected 12M EPS Growth
9818.07%

Price Change

Price % from 50 SMA
-41.85%
Price % from 200 SMA
-63.13%
6 Months
-69.45%
1 Year
-60.23%
2 Years
-47.76%
Click here to see the list of ETFs containing VITL as a top holding :Vital Farms Inc ETFs

Analysis

Company Overview

Vital Farms develops and markets pasture-raised eggs, butter, and other dairy products, sourcing from a nationwide network of small family farms and distributing through major US retailers. Sector: Consumer Staples.

Overview

Vital Farms Inc (VITL) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 0.01%, WACC is 8.33%, and the economic spread is -8.32%. On balance, returns on capital are currently insufficient to clear the funding cost hurdle, which historically correlates with pressure on long-term value creation. Supporting metrics show ROE at 0.05% and ROA at 0.04%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Valuation

On valuation, the company registers trailing P/E of 1798.15, forward P/E of 18.13, PEG of 141.65. Forward P/E is considerably lower than trailing, which indicates earnings estimates are pointing higher — a dynamic that makes current prices look more reasonable on a prospective basis. The PEG ratio is elevated relative to historical norms, implying the market is paying a meaningful premium for the earnings trajectory embedded in analyst estimates. A current ratio of 1.10 signals that short-term coverage is tighter than typical across the company. Taken together, the multiple and liquidity picture suggests a company that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 28.12%, operating margin at 0.04%, and free cash flow margin at 16.47%. Gross margins are moderate, reflecting industry conditions where input costs weigh more heavily on revenue. At this operating margin level, businesses are generating little to no earnings after overhead — a sign of early-stage or high-investment dynamics. At this FCF margin level, the company demonstrate good cash generation relative to the revenue base. Read as a whole, the margin picture suggests a business with strengths in parts but no clear margin dominance end-to-end.

Growth & Forward Outlook

Connecting operational trends with market expectations, TTM revenue growth of 25.26% indicating strong organic momentum at the company level, while the estimated 12-month price change of 19.71%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 9818.1%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Hold

The balance of evidence suggests a neutral posture is appropriate — there are merits here, but also reasons for caution that limit conviction at current levels.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.